Abstract:Background: Sepsis represents a severe manifestation of infection often accompanied by metabolic disorders and mitochondrial dysfunction. Notably, mitochondrial DNA copy number (mtDNA-CN) and the expression of specific mitochondrial genes have emerged as sensitive indicators of mitochondrial function. To investigate the utility of mitochondrial gene expression in peripheral blood cells for distinguishing severe infections and predicting associated outcomes, we conducted a prospective cohort study. Methods: We established a prospective cohort comprising 74 patients with non-sepsis pneumonia and 67 cases of sepsis induced by respiratory infections, aging from 2 to 6 years old. We documented corresponding clinical data and laboratory information and collected blood samples upon initial hospital admission. Peripheral blood cells were promptly isolated, and both total DNA and RNA were extracted. We utilized absolute quantification PCR to assess mtDNA-CN, as well as the expression levels of mt-CO1, mt-ND1, and mt-ATP6. Subsequently, we extended these comparisons to include survivors and non-survivors among patients with sepsis using univariate and multivariate analyses. Receiver operating characteristic (ROC) curves were constructed to assess the diagnostic potential. Results: The mtDNA-CN in peripheral blood cells was significantly lower in the sepsis group. Univariate analysis revealed a significant reduction in the expression of mt-CO1, mt-ND1, and mt-ATP6 in patients with sepsis. However, multivariate analysis did not support the use of mitochondrial function in peripheral blood cells for sepsis diagnosis. In the comparison between pediatric sepsis survivors and non-survivors, univariate analysis indicated a substantial reduction in the expression of mt-CO1, mt-ND1, and mt-ATP6 among non-survivors. Notably, total bilirubin (TB), mt-CO1, mt-ND1, and mt-ATP6 levels were identified as independent risk factors for sepsis-induced mortality. ROC curves were then established for these independent risk factors, revealing areas under the curve (AUCs) of 0.753 for TB (95% CI 0.596–0.910), 0.870 for mt-CO1 (95% CI 0.775–0.965), 0.987 for mt-ND1 (95% CI 0.964–1.000), and 0.877 for mt-ATP6 (95% CI 0.793–0.962). Conclusion: MtDNA-CN and mitochondrial gene expression are closely linked to the severity and clinical outcomes of infectious diseases. Severe infections lead to impaired mitochondrial function in peripheral blood cells. Notably, when compared to other laboratory parameters, the expression levels of mt-CO1, mt-ND1, and mt-ATP6 demonstrate promising potential for assessing the prognosis of pediatric sepsis.

Identification of sepsis-associated mitochondrial genes through RNA and single-cell sequencing approaches

Identification of four mitochondria-related genes in sepsis based on RNA sequencing technology

Identification of biomarkers and pathways of mitochondria in sepsis patients

Identification and validation of a novel mitochondrion-related gene signature for diagnosis and immune infiltration in sepsis

Identification and experimental validation of mitochondria-related genes biomarkers associated with immune infiltration for sepsis

Identification of immune-related mitochondrial metabolic disorder genes in septic shock using bioinformatics and machine learning

Construction and validation of a mitochondria-associated genes prognostic signature and immune microenvironment characteristic of sepsis

Identification of Mitophagy-Related Genes in Sepsis

Identification of Mitochondrial Function-Associated Lncrnas in Septic Mice Myocardium.

The predictive value of peripheral blood cell mitochondrial gene expression in identifying the prognosis in pediatric sepsis at preschool age

Early label-free analysis of mitochondrial redox states by Raman spectroscopy predicts septic outcomes

Deciphering the immune-metabolic nexus in sepsis: a single-cell sequencing analysis of neutrophil heterogeneity and risk stratification

Single-cell RNA sequencing reveals cell–cell communication and potential biomarker in sepsis and septic shock patients

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

The Diagnostic Value of Mitochondrial Mass of Peripheral T Lymphocytes in Early Sepsis

Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis

The emerging role of mtDNA release in sepsis: Current evidence and potential therapeutic targets

New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation

Identification of Iron Metabolism-Related Genes As Diagnostic Signatures in Sepsis by Blood Transcriptomic Analysis

Elucidating common pathogenic transcriptional networks in infective endocarditis and sepsis: integrated insights from biomarker discovery and single-cell RNA sequencing

Mitochondrial dysfunction in febrile illness and sepsis: no clear picture yet